Word: repligen
(lookup in dictionary)
(lookup stats)
Dates: during 1992-1992
Sort By: most recent first
(reverse)
Until 15 or 20 years ago, chemistry was the cornerstone of the pharmaceutical industry. Now companies like Repligen determine the genetic profile of diseases and use biotechnology to devise drugs accordingly, Repligen financial officer Ramesh L. Ratan said...
...Repligen has been working on the drug since 1987, said Ramesh Ratan, senior vice president of the firm. The first human clinical trials, or phase one, began on AIDS patients afflicted with Kaposi's sarcoma--a type of skin cancer--in late June...
Replistatin's potential as a cancer treatment rests in its ability to prevent the formation of blood vessel networks vital to the growth of tumors and lesions, according to a Repligen report...
After the conclusion of the first phase of clinical trials, Repligen plans to conduct two other phases of testing for efficacy of the drug. Ratan said he hopes to receive approval of the Food and Drug Administration for Replistatin by the year...
While it is a long-term investment--Repligen does not expect to be able to market the drug until it is approved by the FDA--Ratan projects a potential market of $200 million...